US Broker Ratings

Revvity, Inc. (RVTY) Stock Analysis: Understanding the Healthcare Innovator’s Growth Potential

Revvity, Inc. (NYSE: RVTY), a significant player in the healthcare sector, is capturing investor attention with its robust presence in the diagnostics and research industry. With..

McKesson Corporation (MCK) Stock Analysis: Eyeing an 11.81% Upside with Robust Healthcare Distribution

McKesson Corporation (NYSE: MCK) stands at the forefront of the healthcare distribution industry, with an impressive market capitalization of $98.51 billion. As a key player in..

Axsome Therapeutics, Inc. (AXSM) Stock Report: Innovative CNS Therapies Drive 21.91% Potential Upside

Axsome Therapeutics, Inc. (NASDAQ: AXSM), a notable player in the biotechnology sector, is capturing attention with its robust portfolio of therapies aimed at central nervous system..

Regencell Bioscience Holdings (RGC) Stock Analysis: Exploring the Intriguing Potential of a $2.48 Billion Market Cap in TCM

Regencell Bioscience Holdings Limited (NASDAQ: RGC) presents an intriguing opportunity for investors interested in the burgeoning field of Traditional Chinese Medicine (TCM). With a market capitalization..

Oscar Health, Inc. (OSCR) Stock Analysis: Navigating Growth Amidst a Challenging Healthcare Landscape

Oscar Health, Inc. (NYSE: OSCR) is emerging as a noteworthy player in the healthcare sector, particularly within the healthcare plans industry. With its market capitalization standing..

IDEXX Laboratories, Inc. (IDXX): Investor Outlook Reveals 24.85% Potential Upside in the Diagnostics Sector

IDEXX Laboratories, Inc. (NASDAQ: IDXX) is making waves in the healthcare sector, particularly within the diagnostics and research industry, with a market capitalization of $44.76 billion...

Danaher Corporation (DHR) Investor Outlook: Exploring a Potential 18.98% Upside with Strong Buy Ratings

Danaher Corporation (NYSE: DHR), a stalwart in the healthcare sector, particularly in the diagnostics and research industry, continues to capture investor attention with its robust market..

Cardinal Health, Inc. (CAH) Stock Analysis: Strong Buy Ratings and a 9.22% Upside Potential

Cardinal Health, Inc. (NYSE: CAH) stands as a pivotal player in the healthcare sector, particularly in the medical distribution industry. With a market capitalization of $53.52..

Smith & Nephew (SNN) Stock Analysis: Exploring a Potential 11% Upside in Medical Devices

Smith & Nephew SNATS, Inc. (NYSE: SNN), a venerable name in the medical devices industry, is making waves with intriguing potential for investors. Headquartered in Watford,..

Globus Medical, Inc. (GMED) Stock Analysis: Exploring a 37% Potential Upside in the Medical Device Sector

For investors with an eye on the healthcare sector, Globus Medical, Inc. (NYSE: GMED) presents a compelling opportunity, particularly given the company’s potential upside of 37.34%...

Rhythm Pharmaceuticals, Inc. (RYTM) Investor Outlook: Strong Buy Ratings Signal Potential 31% Upside

Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) is capturing investor attention with its robust growth potential and strong analyst ratings. As a commercial-stage biopharmaceutical company, Rhythm Pharmaceuticals focuses..

Stevanato Group S.p.A. (STVN) Stock Analysis: Evaluating a 27.54% Potential Upside in the Healthcare Sector

For investors eyeing opportunities in the healthcare sector, Stevanato Group S.p.A. (NYSE: STVN) offers an intriguing investment case. With its shares currently priced at $19.17, the..

BridgeBio Pharma, Inc. (BBIO) Stock Analysis: Exploring the 28.75% Upside Potential for Investors

BridgeBio Pharma, Inc. (NASDAQ: BBIO) is garnering attention in the biotechnology sector, not only for its innovative approach to tackling genetic diseases but also for its..

Telix Pharmaceuticals Limited (TLX) Stock Analysis: Unveiling a 101.56% Potential Upside in Biotech Innovation

Telix Pharmaceuticals Limited (ASX: TLX) presents a compelling opportunity for investors with its innovative approach in the biotechnology sector. As a commercial-stage biopharmaceutical company, Telix is..

AptarGroup, Inc. (ATR) Stock Analysis: Unlocking Potential with a 24.75% Upside

AptarGroup, Inc. (NYSE: ATR), a leading player in the Healthcare sector, specifically within the Medical Instruments & Supplies industry, presents an intriguing opportunity for investors seeking..

Avantor, Inc. (AVTR) Stock Analysis: Navigating Challenges in the Healthcare Sector

Avantor, Inc. (AVTR), a prominent player in the healthcare sector, finds itself at a pivotal juncture as it navigates a complex landscape characterized by both opportunities..

Edwards Lifesciences Corporatio (EW)

⚠️ No article content returned.

..

Bruker Corporation (BRKR) Stock Analysis: Navigating Growth in the Medical Devices Sector

As the medical devices industry continues to thrive amidst rapid technological advancements, Bruker Corporation (NASDAQ: BRKR) stands out with its diverse portfolio of cutting-edge scientific instruments..

Sanofi (SNY) Stock Analysis: Unveiling a 23% Potential Upside for Investors

Sanofi (SNY), a titan in the healthcare sector, continues to capture the attention of investors with its impressive market strategies and robust pipeline of therapeutic solutions...

Option Care Health, Inc. (OPCH) Stock Analysis: Unpacking the 29.18% Potential Upside

Option Care Health, Inc. (NASDAQ: OPCH) stands as a formidable player within the healthcare sector, specifically in the medical care facilities industry. With a market capitalization..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds